A PKA Inhibitor Motif within Smoothened Controls Hedgehog Signal Transduction
Open accessPreprint — published as 10.1038/s41594-022-00838-z · Paper page
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index; none of the 92 sources its claims cite is checked for support yet.
Abstract
The Hedgehog (Hh) cascade is central to development, tissue homeostasis, and cancer. A pivotal step in Hh signal transduction is the activation of GLI transcription factors by the atypical G protein-coupled receptor (GPCR) Smoothened (SMO). How SMO activates GLI has remained unclear for decades. Here we show that SMO employs a decoy substrate sequence to physically block the active site of the PKA catalytic subunit (PKA-C) and extinguish its enzymatic activity. As a result, GLI is released from phosphorylation-induced inhibition. Using a combination of in vitro , cellular, and organismal models, we demonstrate that interfering with SMO / PKA pseudosubstrate interactions prevents Hh signal transduction. The mechanism we uncovered echoes one utilized by the Wnt cascade, revealing an unexpected similarity in how these two essential developmental and cancer pathways signal intracellularly. More broadly, our findings define a new mode of GPCR-PKA communication that may be harnessed by a range of membrane receptors and kinases.
Overview
CoChat Summary
TL;DR
The paper shows that SMO’s proximal C-terminal tail contains a PKA pseudosubstrate/PKI motif that binds the PKA catalytic subunit (PKA-C), occludes its active site, and blocks GLI phosphorylation, thereby promoting Hedgehog signal transduction. Disrupting this motif prevents SMO–PKA-C interaction and Hh signaling in cultured cells and zebrafish.
Key findings
- SMO residues 615–638 form a PKI-like pseudosubstrate motif with a non-phosphorylatable alanine at the P-site, arginines at P−2/P−3, and a tryptophan at P−13. A fluorescent SMO PKI peptide bound human PKA-Cα with KD = 823 nM and mouse PKA-Cα with KD = 911 nM; binding was ATP-dependent (EC50 = 19.2 μM for human, 0.59 μM for mouse) and was blocked by the WRR mutation. SPR showed recombinant SMO pCT bound mouse PKA-Cα with KD = 752 nM, whereas PKIα(5–24) bound with KD = 1.1 nM.
- SMO PKI peptides inhibited PKA-C enzymatic activity in vitro; recombinant SMO pCT was more potent (IC50 = 10.9 μM) than SMO PKI peptides (IC50 = 50–125 μM), and the WRR mutation restored PKA-C activity. NMR showed the SMO peptide induced chemical shift perturbations in the PKA-C kinase core and was displaced by PKIα(5–24), indicating overlapping active-site binding.
- In cells, WRR and A635S SMO mutants failed to bind or colocalize with PKA-C, failed to block PKA-C-mediated CREB reporter activation, and were almost completely inactive in GLI transcriptional reporter assays in Smo−/− MEFs. In zebrafish, wild-type SMO restored slow muscle specification in smo−/− embryos, whereas WRR or A635S mutants did not.
- The paper proposes an avidity-based mechanism: additional PKA-C-binding sequences exist in the SMO pCT and distal C-tail (dCT), full-length C-tail interactions are only partially blocked by WRR, and a peptide array identified additional PKA-C-binding motifs. This resembles Wnt pathway LRP5/6 pseudosubstrate inhibition of GSK-3β.
Methods
- In vitro binding and activity: fluorescence polarization with purified human/mouse PKA-Cα and SMO peptides; surface plasmon resonance with GST-SMO pCT and PKA-Cα; NMR spectroscopy with 2H,15N-labeled PKA-Cα and SMO peptides; peptide arrays; and a coupled spectrophotometric PKA-C activity assay using Kemptide as substrate.
- Cellular and organismal assays: BRET and coimmunoprecipitation in HEK293 cells; live-cell confocal imaging in HEK293, IMCD3, and NIH3T3 cells; CREB and GLI luciferase reporter assays; flow cytometry for SMO surface expression; and zebrafish embryo immunohistochemistry for slow muscle markers.
- Statistics and reproducibility: GraphPad Prism t-tests or ANOVA as indicated; experiments reproduced on at least two independent occasions; no statistical method was used to predetermine sample size; randomization and blinding were not used.
Limitations
- Stated: no statistical method was used to predetermine sample size; randomization and blinding methods were not used. The authors note that future structural studies of full-length SMO/PKA-C complexes are needed, that determining the relative stoichiometry of SMO and free PKA-C in cilia remains extremely challenging due to limited signal-to-noise and spatial resolution of current tools, and that peptide microarrays are not ideal for detecting binding involving extensive secondary structure.
- Evident from the text: many mechanistic conclusions rely on overexpression systems, truncated SMO constructs (e.g., SMO657/SMO674), and mutant SMO or PKA-C constructs; the isolated SMO PKI motif binds PKA-C much more weakly than canonical PKIα(5–24), so its in vivo function is proposed to depend on avidity, membrane localization, and additional C-tail determinants rather than on high-affinity binding alone.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 40 Not checked · 107 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using a combination of in vitro, cellular, and organismal models, we demonstrate that interfering with SMO / PKA pseudosubstrate interactions prevents Hh signal transduction.”
§ A PKA Inhibitor Motif within SMOOTHENED Controls Hedgehog Signal Transduction > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inspection of the mouse SMO sequence revealed a region within the pCT (residues 615–638) that bears the hallmarks of a PKA-C pseudosubstrate (Fig. 1a).”
§ A PKA Inhibitor Motif within SMOOTHENED Controls Hedgehog Signal Transduction > RESULTS > SMO binds and inhibits PKA-C as a pseudosubstrate
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Second, SMO contains arginines at the P−2 and P−3 positions that are essential in other pseudosubstrates (PKI and PKA-RI) for binding the PKA-C active site35–38.”
§ A PKA Inhibitor Motif within SMOOTHENED Controls Hedgehog Signal Transduction > RESULTS > SMO binds and inhibits PKA-C as a pseudosubstrate
What the sources say
- Not checked yetcites [35] matched to “Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase.” (1985) source
- Not checked yetcites [36] matched to “An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase” (1985) source
- Not checked yetcites [37] matched to “Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3‘:5‘-monophosphate-dependent protein kinase.” (1978) source
- Not checked yetcites [38] matched to “Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.” (1986) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“First, in contrast to canonical PKA-C substrates, which contain a serine or threonine at a canonical phosphorylation site (P-site)34, SMO possesses a non-phosphorylatable residue, alanine, at this position.”
§ A PKA Inhibitor Motif within SMOOTHENED Controls Hedgehog Signal Transduction > RESULTS > SMO binds and inhibits PKA-C as a pseudosubstrate
What the sources say
- Not checked yetcites [34] 1989, Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein, J Biol Chem source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These interactions showed pseudosubstrate characteristics: they were strongly ATP-dependent45 (EC50 for ATP = 19.2 μM (human) or 0.59 μM (mouse), Fig. 1b (bottom) and Extended Data Fig. 2a (right)) and were blocked by alanine substitution of the P−2 / P−3 arginines and the P−13 tryptophan, hereafter referred to as the “WRR mutation” (Fig. 1c, Extended Data Fig. 2b).”
§ A PKA Inhibitor Motif within SMOOTHENED Controls Hedgehog Signal Transduction > RESULTS > SMO binds and inhibits PKA-C as a pseudosubstrate
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 147 claims and to verify the 92 references still open.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 51
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“SMO PKI peptides also blocked PKA-C enzymatic activity in vitro, as assessed via a PKA-C substrate phosphorylation assay47, with an extended length peptide (Fig. 1a) inhibiting PKA-C more profoundly (Fig. 3a).”
“a, Expression levels of SMO constructs in Fig. 3a, assessed by whole-cell nanoluc measurements.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“we excluded from analysis any spots that were not observed consistently across replicates.”
“No data were excluded from the analyses.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“direct surface plasmon resonance (SPR) binding studies revealed that a recombinant protein encompassing the entire 93 amino-acid SMO pCT bound specifically to mouse PKA-Cα (Fig. 1d).”
“d, Exemplary steady-state analysis of binding interactions between human PKA-Cɑ and a recombinant wild-type SMO pCT, with a KD of 703 +/− 0.003 nM (dotted line) as assessed by SPR.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Stoichiometric amounts of SMO PKI peptide (hereafter referred to as SMO-PKI) were then added to the PKA-Cα/ATPγN complex until saturation (1:0, 1:1, 1:2, and 1:4 SMO-PKI:PKA-C/ATPγN molar ratio), with a concentration of SMO-PKI ranging from 0.1 to 0.4 mM.”
“The NMR experiments were performed on 100 μM uniformly 2H, 15N-labeled PKA-Cα sample”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Lee, W., Tonelli, M., & Markley, J. L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu830 · Cited by 2,045
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
Self-citationThe mechanisms of Hedgehog signalling and its roles in development and disease
Briscoe, J., & Thérond, P. P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3598 · Cited by 1,751
Cited by
Primary cilia as dynamic and diverse signalling hubs in development and disease
Mill, P., Christensen, S. T., & Pedersen, L. B. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00587-9 · Cited by 417
Hedgehog signaling in tissue homeostasis, cancers and targeted therapies
Jing, J., Wu, Z., Wang, J., Luo, G., Lin, H., Fan, Y., & Zhou, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01559-5 · Cited by 247
Cellular and molecular mechanisms of Hedgehog signalling
Zhang, Y., & Beachy, P. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00591-1 · Cited by 196
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Zhang, H., Liu, Y., Liu, J., Chen, J., Wang, J., Hua, H. M., & Jiang, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01524-x · Cited by 172
Ingham, P. W. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.04.003 · Cited by 170
Metadata
- Authors
- Happ, J. T., Arveseth, C. D., Bruystens, J., Bertinetti, D., Nelson, I. B., Olivieri, C., Hedeen, D. S., Zhu, J.-F., Capener, J. L., Bröckel, J. W., Vu, L., King, C. C., Ruiz-Perez, V. L., Veglia, G., Herberg, F. W., Taylor, S. S., & Myers, B. R.
- Affiliations
- University of Utah (US)
- Washington University in St. Louis (US)
- University of California San Diego (US)
- University of Kassel (DE)
- University of Minnesota (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Taylor, Susan S.
- Myers, Benjamin R.
- ORCID
- Venue
- Nature Structural & Molecular Biology
- Publisher
- openRxiv
- Published
- 2021-07-06
- Volume
- 29
- Issue
- 10
- Pages
- 990-999
- ISSN
- 1545-9985 (ISSN-L)
- PMC
- PMC9696579
- OpenAlex
- W4302362492
- Cited by
- 74
- References
- 117
- Citations by year
- 2026: 21 · 2025: 15 · 2024: 15 · 2023: 20 · 2022: 2
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- University of Pennsylvania
- Huntsman Cancer Institute
- Deutsche Forschungsgemeinschaft
- Universität Kassel
- National Institutes of Health (R03TR002947)
- Perelman School of Medicine, University of Pennsylvania
- National Cancer Institute (R21CA274595, R15CA235749)
- National Institute of General Medical Sciences (R01GM100310, R01GM143276, R35GM133672, R35GM130389)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- Hedgehog signaling, Smoothened, Gli transcription factors, protein kinase A, PKA catalytic subunit, G protein-coupled receptors, Wnt signaling, signal transduction
- MeSH terms
- Smoothened Receptor, Antineoplastic Agents, Transcription Factors, Signal Transduction, Cyclic AMP-Dependent Protein Kinases, Drosophila Proteins, Receptors, G-Protein-Coupled, Intracellular Signaling Peptides and Proteins, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A PKA Inhibitor Motif within Smoothened Controls Hedgehog Signal Transduction. https://app.cochat.ai/papers/10.1101/2021.07.05.451193
- The paper
- Happ, J. T., Arveseth, C. D., Bruystens, J., Bertinetti, D., Nelson, I. B., Olivieri, C., Hedeen, D. S., Zhu, J.-F., Capener, J. L., Bröckel, J. W., Vu, L., King, C. C., Ruiz-Perez, V. L., Veglia, G., Herberg, F. W., Taylor, S. S., & Myers, B. R. (2021). A PKA Inhibitor Motif within Smoothened Controls Hedgehog Signal Transduction. Nature Structural & Molecular Biology. https://doi.org/10.1101/2021.07.05.451193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.